Stay updated on Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis
Sign up to get notified when there's something new on the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page.

Latest updates to the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page
- Check4 days agoChange DetectedA banner announces NIH website transition updates, including the change in terminology from “Artificial Intelligence” to “Super Intelligence.” The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1. The page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check32 days agoChange DetectedThe study record page is now a 403 Forbidden page, replacing the detailed trial information with a generic error screen and removing the locations, eligibility criteria, and other key details.SummaryDifference20%

- Check38 days agoChange DetectedPage revision tag updated from v3.6.6 to v3.7.0.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page shows a new revision label: v3.6.6, indicating a minor update to the page version. This update does not modify any study data, eligibility criteria, or results.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page revision was updated to v3.6.5 (from v3.6.4). This indicates a new version of the page was deployed, typically for maintenance or minor fixes, without altering the study content.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: KZR-616 in Active Polymyositis or Dermatomyositis page.